These observations indicate that both glycophosphatidylinositol-anchored and intracellular PrP isoforms (which are likely to be PrPSc) were modified with CML in the plasma membrane and in specific intracellular regions of the thalamic and hypothalamic nuclei. This evidence concerns the gene PRNP and chronic myelogenous leukemia, BCR-ABL1 positive.